BJL
COCP icon

Brighton Jones LLC’s Cocrystal Pharma COCP Stock Holding History

Brighton Jones LLC’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,333
Closed -$11K – 474
2022
Q2 		$11K Hold
2,333
– – ﹤0.01% 471
2022
Q1 		$15K Hold
2,333
– – ﹤0.01% 513
2021
Q4 		$18K Sell
2,333
-667
-22% -$6.83K ﹤0.01% 526
2021
Q3 		$38K Hold
3,000
– – ﹤0.01% 481
2021
Q2 		$45K Hold
3,000
– – ﹤0.01% 474
2021
Q1 		$50K Hold
3,000
– – ﹤0.01% 425
2020
Q4 		$49K Buy
3,000
+1,500
+100% +$20.8K ﹤0.01% 392
2020
Q3 		$17K Hold
1,500
– – ﹤0.01% 330
2020
Q2 		$27K Buy
+1,500
New +$18.4K ﹤0.01% 295

Other funds holding COCP

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Brighton Jones LLC's COCP Position: Q3 2022 in Review

Brighton Jones LLC sold out of Cocrystal Pharma (COCP) in Q3 2022, closing a stake of 2,333 shares — an estimated $11K sold.

Brighton Jones LLC first reported a position in COCP in Q2 2020 and held it in 9 quarters. The position peaked at $50K in Q1 2021. 27 funds tracked by Wall St. Rank hold COCP as of Q3 2022.

  • Brighton Jones LLC reported no remaining Cocrystal Pharma position as of Q3 2022 after selling out during the quarter.
  • Brighton Jones LLC sold 2,333 Cocrystal Pharma shares in Q3 2022, an estimated $11K.
  • Brighton Jones LLC first reported a position in Cocrystal Pharma in Q2 2020 and held it in 9 quarters.
  • Brighton Jones LLC's Cocrystal Pharma position peaked at $50K in Q1 2021.
  • 27 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q3 2022.

Based on Brighton Jones LLC's 13F filing for Q3 2022, filed 9 Nov 2022.